AMRX
Price
$7.50
Change
+$0.15 (+2.04%)
Updated
May 15 closing price
Capitalization
1.87B
83 days until earnings call
ANIP
Price
$59.53
Change
-$0.84 (-1.39%)
Updated
May 15 closing price
Capitalization
1.43B
82 days until earnings call
Ad is loading...

AMRX vs ANIP

Header iconAMRX vs ANIP Comparison
Open Charts AMRX vs ANIPBanner chart's image
Amneal Pharmaceuticals
Price$7.50
Change+$0.15 (+2.04%)
Volume$1.59M
Capitalization1.87B
ANI Pharmaceuticals
Price$59.53
Change-$0.84 (-1.39%)
Volume$597.43K
Capitalization1.43B
AMRX vs ANIP Comparison Chart
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ANIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRX vs. ANIP commentary
May 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a Hold and ANIP is a Buy.

Ad is loading...
COMPARISON
Comparison
May 16, 2025
Stock price -- (AMRX: $7.50 vs. ANIP: $59.53)
Brand notoriety: AMRX and ANIP are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMRX: 78% vs. ANIP: 137%
Market capitalization -- AMRX: $1.87B vs. ANIP: $1.43B
AMRX [@Pharmaceuticals: Other] is valued at $1.87B. ANIP’s [@Pharmaceuticals: Other] market capitalization is $1.43B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whileANIP’s FA Score has 0 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • ANIP’s FA Score: 0 green, 5 red.
According to our system of comparison, AMRX is a better buy in the long-term than ANIP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 4 TA indicator(s) are bullish while ANIP’s TA Score has 5 bullish TA indicator(s).

  • AMRX’s TA Score: 4 bullish, 5 bearish.
  • ANIP’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ANIP is a better buy in the short-term than AMRX.

Price Growth

AMRX (@Pharmaceuticals: Other) experienced а +0.54% price change this week, while ANIP (@Pharmaceuticals: Other) price change was -16.78% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.68%. For the same industry, the average monthly price growth was +10.59%, and the average quarterly price growth was +26.70%.

Reported Earning Dates

AMRX is expected to report earnings on Aug 07, 2025.

ANIP is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.68% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRX($1.87B) has a higher market cap than ANIP($1.43B). AMRX has higher P/E ratio than ANIP: AMRX (90.00) vs ANIP (79.85). ANIP YTD gains are higher at: 7.688 vs. AMRX (-5.303). AMRX has higher annual earnings (EBITDA): 400M vs. ANIP (107M). ANIP has more cash in the bank: 221M vs. AMRX (91.5M). ANIP has less debt than AMRX: ANIP (286M) vs AMRX (2.75B). AMRX has higher revenues than ANIP: AMRX (2.39B) vs ANIP (487M).
AMRXANIPAMRX / ANIP
Capitalization1.87B1.43B131%
EBITDA400M107M374%
Gain YTD-5.3037.688-69%
P/E Ratio90.0079.85113%
Revenue2.39B487M492%
Total Cash91.5M221M41%
Total Debt2.75B286M962%
FUNDAMENTALS RATINGS
AMRX vs ANIP: Fundamental Ratings
AMRX
ANIP
OUTLOOK RATING
1..100
1762
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
92
Overvalued
PROFIT vs RISK RATING
1..100
5263
SMR RATING
1..100
9992
PRICE GROWTH RATING
1..100
5860
P/E GROWTH RATING
1..100
2495
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMRX's Valuation (92) in the Pharmaceuticals Major industry is in the same range as ANIP (92) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew similarly to ANIP’s over the last 12 months.

AMRX's Profit vs Risk Rating (52) in the Pharmaceuticals Major industry is in the same range as ANIP (63) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew similarly to ANIP’s over the last 12 months.

ANIP's SMR Rating (92) in the Pharmaceuticals Other industry is in the same range as AMRX (99) in the Pharmaceuticals Major industry. This means that ANIP’s stock grew similarly to AMRX’s over the last 12 months.

AMRX's Price Growth Rating (58) in the Pharmaceuticals Major industry is in the same range as ANIP (60) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew similarly to ANIP’s over the last 12 months.

AMRX's P/E Growth Rating (24) in the Pharmaceuticals Major industry is significantly better than the same rating for ANIP (95) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew significantly faster than ANIP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXANIP
RSI
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
74%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
69%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
71%
Advances
ODDS (%)
Bullish Trend 9 days ago
80%
Bullish Trend 9 days ago
74%
Declines
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 1 day ago
70%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
74%
View a ticker or compare two or three
Ad is loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ANIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY590.462.87
+0.49%
SPDR® S&P 500® ETF
BTC.X103744.640000205.226560
+0.20%
Bitcoin cryptocurrency
GME28.63-0.10
-0.35%
GameStop Corp
AAPL211.45-0.88
-0.41%
Apple
TSLA342.82-4.86
-1.40%
Tesla

AMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with PAHC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
+2.04%
PAHC - AMRX
45%
Loosely correlated
+2.01%
TEVA - AMRX
37%
Loosely correlated
-0.12%
EBS - AMRX
37%
Loosely correlated
-2.66%
ZTS - AMRX
36%
Loosely correlated
+3.51%
PRGO - AMRX
35%
Loosely correlated
+1.08%
More

ANIP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIP has been loosely correlated with ORGO. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIP jumps, then ORGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIP
1D Price
Change %
ANIP100%
-1.39%
ORGO - ANIP
49%
Loosely correlated
+0.66%
PRGO - ANIP
39%
Loosely correlated
+1.08%
DRRX - ANIP
38%
Loosely correlated
-4.74%
EBS - ANIP
28%
Poorly correlated
-2.66%
AMRX - ANIP
26%
Poorly correlated
+2.04%
More